Research ArticlePsoriatic Arthritis
Comparison of Composite Measure Remission Targets in Psoriatic Arthritis
Flora Farkas, Natsumi Ikumi, Musaab Elmamoun, Agnes Szentpetery and Oliver FitzGerald
The Journal of Rheumatology August 2021, 48 (8) 1272-1278; DOI: https://doi.org/10.3899/jrheum.200556
Flora Farkas
1F. Farkas, MD, St. Vincent’s University Hospital, Dublin, Ireland, and Borsod-Abaúj-Zemplén County Center Hospital and University Teaching Hospital, Department of Rheumatology, Miskolc, Hungary;
Natsumi Ikumi
2N. Ikumi, MD, St. Vincent’s University Hospital, Dublin, Ireland, and Nihon University School of Medicine, Division of Hematology and Rheumatology, Tokyo, Japan;
Musaab Elmamoun
3M. Elmamoun, MD, MBBS, MRCPI, St. Vincent’s University Hospital, Dublin, Ireland, and Worcestershire Acute Hospitals NHS Trust, Worcester, UK;
Agnes Szentpetery
4A. Szentpetery, MD, PhD, St. Vincent’s University Hospital, Dublin, Ireland, and Uppsala University Hospital, Uppsala, Sweden;
Oliver FitzGerald
5O. FitzGerald, MD, FRCP, FRCPI, St. Vincent’s University Hospital, and Conway Institute for Biomolecular Research, University College Dublin School of Medicine, Dublin, Ireland.
In this issue
The Journal of Rheumatology
Vol. 48, Issue 8
1 Aug 2021
Comparison of Composite Measure Remission Targets in Psoriatic Arthritis
Flora Farkas, Natsumi Ikumi, Musaab Elmamoun, Agnes Szentpetery, Oliver FitzGerald
The Journal of Rheumatology Aug 2021, 48 (8) 1272-1278; DOI: 10.3899/jrheum.200556